Malignant Hypertension: Challenges and Strategies
Author Information
Author(s): Tsige Abate Wondesen, Ayele Siraye Genzeb
Primary Institution: School of Pharmacy, College of Health Sciences, Debre Berhan University, Ethiopia
Hypothesis
What are the current challenges, prevention strategies, and future perspectives regarding malignant hypertension?
Conclusion
Malignant hypertension requires prompt treatment and has several effective treatment options available.
Supporting Evidence
- Malignant hypertension is characterized by extremely high blood pressure and acute damage to organs.
- Prompt treatment is crucial to prevent severe complications and organ damage.
- First-line treatments include labetalol and nicardipine, with alternatives like urapidil and nitroprusside.
Takeaway
Malignant hypertension is a very serious condition that can damage organs, and it needs quick treatment. There are medicines that can help manage it.
Methodology
This review examines the pathogenesis, predisposing factors, therapy, and preventive strategies for malignant hypertension.
Potential Biases
Potential biases may arise from the reliance on consensus guidelines due to the scarcity of data.
Limitations
There is limited data on malignant hypertension, and many guidelines are based on consensus rather than extensive research.
Participant Demographics
The study included patients diagnosed with malignant hypertension, with a noted higher incidence among Black African/Afro-Caribbean ethnicities.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website